688105 诺唯赞
已收盘 12-19 15:00:01
资讯
新帖
简况
诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%
证券之星 · 12-17 22:44
诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%
诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证
智通财经 · 12-17 16:13
诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%
证券之星 · 12-08
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%
证券之星 · 12-01
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%
证券之星 · 11-26
诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%
每周股票复盘：诺唯赞（688105）拟为控股子公司提供担保
证券之星 · 11-23
每周股票复盘：诺唯赞（688105）拟为控股子公司提供担保
诺唯赞（688105）披露向控股子公司提供财务资助暨关联交易事项，11月20日股价下跌0.6%
证券之星 · 11-20
诺唯赞（688105）披露向控股子公司提供财务资助暨关联交易事项，11月20日股价下跌0.6%
诺唯赞（688105）披露拟为控股子公司提供担保议案，11月19日股价下跌1.19%
证券之星 · 11-19
诺唯赞（688105）披露拟为控股子公司提供担保议案，11月19日股价下跌1.19%
每周股票复盘：诺唯赞（688105）将召开临时股东会审议多项议案
证券之星 · 11-16
每周股票复盘：诺唯赞（688105）将召开临时股东会审议多项议案
诺唯赞（688105）披露拟取消监事会并修订公司章程，11月11日股价上涨0.17%
证券之星 · 11-11
诺唯赞（688105）披露拟取消监事会并修订公司章程，11月11日股价上涨0.17%
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万元
证券之星 · 11-09
每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万元
诺唯赞(688105.SH)子公司取得两项医疗器械注册证
智通财经 · 11-06
诺唯赞(688105.SH)子公司取得两项医疗器械注册证
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.43%
证券之星 · 11-03
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.43%
每周股票复盘：诺唯赞（688105）Q3净利增74.55%
证券之星 · 11-02
每周股票复盘：诺唯赞（688105）Q3净利增74.55%
诺唯赞（688105）披露2025年第三季度报告，10月29日股价上涨0.95%
证券之星 · 10-29
诺唯赞（688105）披露2025年第三季度报告，10月29日股价上涨0.95%
图解诺唯赞三季报：第三季度单季净利润同比增长74.55%
证券之星 · 10-29
图解诺唯赞三季报：第三季度单季净利润同比增长74.55%
诺唯赞跌3.56% 2021年上市超募9亿元
中金财经 · 10-20
诺唯赞跌3.56% 2021年上市超募9亿元
每周股票复盘：诺唯赞（688105）已回购40,000股支付约97.38万元
证券之星 · 10-12
每周股票复盘：诺唯赞（688105）已回购40,000股支付约97.38万元
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌0.47%
证券之星 · 10-09
诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌0.47%
诺唯赞(688105.SH)子公司产品取得医疗器械注册证
智通财经 · 09-24
诺唯赞(688105.SH)子公司产品取得医疗器械注册证
公司概况
公司名称：
南京诺唯赞生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-11-15
主营业务：
南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂、POCT诊断试剂和仪器。截至2025年6月30日，公司共获得121项发明专利授权，发明专利申请累计269项。
发行价格：
55.00
{"stockData":{"symbol":"688105","market":"SH","secType":"STK","nameCN":"诺唯赞","latestPrice":20.15,"timestamp":1766127601000,"preClose":20.02,"halted":0,"volume":1759946,"delay":0,"changeRate":0.0065,"floatShares":398000000,"shares":398000000,"eps":-0.0746,"marketStatus":"已收盘","change":0.13,"latestTime":"12-19 15:00:01","open":20.07,"high":20.29,"low":20,"amount":35441600,"amplitude":0.0145,"askPrice":20.15,"askSize":4,"bidPrice":20.07,"bidSize":94,"shortable":0,"etf":0,"ttmEps":-0.0746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":20.02,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":22.02,"lowLimit":18.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":397734544,"isCdr":false,"pbRate":2.09,"roa":"--","roe":"0.17%","epsLYR":-0.05,"committee":0.575194,"marketValue":8014000000,"turnoverRate":0.0044,"status":0,"afterMarket":{"amount":0,"volume":0,"close":20.15,"buyVolume":0,"sellVolume":0,"time":1766129637768,"indexStatus":"已收盘 12-19 15:30:00","preClose":20.02},"floatMarketCap":8014000000},"requestUrl":"/m/hq/s/688105/wiki","defaultTab":"wiki","newsList":[{"id":"2592916149","title":"诺唯赞（688105）披露公司产品取得欧盟CE IVDR认证，12月17日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592916149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592916149?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:44","pubTimestamp":1765982676,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，诺唯赞报收于19.95元，较前一交易日下跌0.1%，最新总市值为79.35亿元。公司近日发布公告称，南京诺唯赞生物科技股份有限公司六项呼吸道病原体检测试剂盒获得欧盟CE IVDR认证，可在欧盟国家及认可欧盟CE认证的国家销售。本次认证表明公司质量管理体系符合欧盟要求，有助于提升公司国际市场竞争能力，但具体销售情况受多种因素影响，尚无法预测对未来业绩的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700040408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216","FSXEmain","FESXmain"],"gpt_icon":0},{"id":"2592696778","title":"诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592696778","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592696778?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:13","pubTimestamp":1765959238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)公告，公司六项呼吸道病原体核酸检测试剂盒于近日取得欧盟CE IVDR认证，可在欧盟国家和认可欧盟CE认证的国家进行销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4109","BK0216","FESXmain","CE","688105","BK4588","FSXEmain"],"gpt_icon":0},{"id":"2589339323","title":"诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，12月08日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339323","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339323?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187570,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，诺唯赞报收于21.83元，较前一交易日下跌0.14%，最新总市值为86.83亿元。该股当日开盘21.96元，最高22.08元，最低21.73元，成交额达2658.02万元，换手率为0.31%。公司近日发布公告称，南京诺唯赞生物科技股份有限公司于2025年12月5日召开2025年第二次临时股东会，审议通过《关于控股子公司增资扩股暨引入外部投资者且公司为控股子公司提供担保的议案》。议案获得普通股股东99.9545%同意，中小投资者同意比例为99.2253%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2588725701","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，12月1日股价下跌1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725701?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582938,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，诺唯赞报收于22.53元，较前一交易日下跌1.14%，最新总市值为89.61亿元。近日，诺唯赞发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购金额为500万元至1000万元，用于员工持股计划或股权激励，回购价格不超过30元/股，实施期限为2025年6月19日至2026年6月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2586326310","title":"诺唯赞（688105）披露控股子公司增资扩股暨引入外部投资者公告，11月26日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586326310","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586326310?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:43","pubTimestamp":1764168201,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，诺唯赞报收于22.73元，较前一交易日上涨0.26%，最新总市值为90.41亿元。公告显示，诺唯赞的控股子公司液滴英国拟进行增资扩股，引入国君创投SPV、南京市紫金生物医药产业投资基金、九安香港、华西银峰投资等外部投资者，合计投资金额包括人民币和美元。本次增资完成后，诺唯赞对液滴英国的持股比例将降至56.99%，液滴英国仍为公司合并报表范围内的控股子公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600039277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2585629106","title":"每周股票复盘：诺唯赞（688105）拟为控股子公司提供担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2585629106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585629106?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:34","pubTimestamp":1763843652,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，诺唯赞报收于22.16元，较上周的23.82元下跌6.97%。本周，诺唯赞11月17日盘中最高价报24.01元。本周关注点公司公告汇总：诺唯赞拟为控股子公司液滴英国增资扩股提供担保，公司控制股权比例将降至56.99%。公司公告汇总：诺唯赞将于2025年12月5日召开第二次临时股东会审议子公司增资事项。股权登记日为2025年11月28日，会议将审议前述子公司增资扩股及相关担保议案，并对中小投资者单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2584625158","title":"诺唯赞（688105）披露向控股子公司提供财务资助暨关联交易事项，11月20日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584625158?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:44","pubTimestamp":1763649865,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，诺唯赞报收于23.16元，较前一交易日下跌0.6%，最新总市值为92.12亿元。公司近日发布公告称，南京诺唯赞生物科技股份有限公司于2025年11月20日召开2025年第一次临时股东会，审议通过《关于向控股子公司提供财务资助暨关联交易的议案》。本次关联交易事项已履行相应的审议程序，北京市天元律师事务所对本次会议出具了法律意见书，认为会议召集、召开程序合法有效，表决结果有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2584947177","title":"诺唯赞（688105）披露拟为控股子公司提供担保议案，11月19日股价下跌1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947177","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947177?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:34","pubTimestamp":1763562863,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，诺唯赞报收于23.3元，较前一交易日下跌1.19%，最新总市值为92.67亿元。该股当日开盘23.58元，最高23.7元，最低23.11元，成交额达3413.79万元，换手率为0.37%。近日，南京诺唯赞生物科技股份有限公司发布公告称，公司将于2025年12月5日召开2025年第二次临时股东会，会议将审议《关于控股子公司增资扩股暨引入外部投资者且公司为控股子公司提供担保的议案》。公告显示，该议案将对中小投资者单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2583104654","title":"每周股票复盘：诺唯赞（688105）将召开临时股东会审议多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2583104654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583104654?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:59","pubTimestamp":1763240347,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，诺唯赞报收于23.82元，较上周的22.97元上涨3.7%。本周，诺唯赞11月14日盘中最高价报24.35元。诺唯赞当前最新总市值94.74亿元，在生物制品板块市值排名34/51，在两市A股市值排名2005/5165。本周关注点公司公告汇总：诺唯赞将于2025年11月20日召开第一次临时股东会，审议向控股子公司提供财务资助、取消监事会并修订公司章程等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2582136772","title":"诺唯赞（688105）披露拟取消监事会并修订公司章程，11月11日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582136772","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582136772?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:40","pubTimestamp":1762872039,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，诺唯赞报收于23.67元，较前一交易日上涨0.17%，最新总市值为94.14亿元。该股当日开盘23.64元，最高23.75元，最低23.44元，成交额达3608.08万元，换手率为0.38%。公司近日发布公告称，将于2025年11月20日召开第一次临时股东会，审议包括取消监事会并修订公司章程的议案。根据公告，本次修订拟取消公司监事会，并由董事会审计委员会承接其相关职能，同时拟在董事会中增设职工代表董事席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100041165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2582610318","title":"每周股票复盘：诺唯赞（688105）已回购127,703股耗资近300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582610318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582610318?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:26","pubTimestamp":1762633571,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，诺唯赞报收于22.97元，较上周的23.51元下跌2.3%。本周，诺唯赞11月3日盘中最高价报23.67元。11月7日盘中最低价报22.7元。诺唯赞当前最新总市值91.36亿元，在生物制品板块市值排名33/51，在两市A股市值排名2054/5166。本周关注点公司公告汇总：诺唯赞已累计回购127,703股，支付资金总额2,999,704.25元。公司将继续按照相关规定推进回购，并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2581805783","title":"诺唯赞(688105.SH)子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2581805783","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581805783?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:12","pubTimestamp":1762420350,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞 发布公告，公司全资子公司南京诺唯赞医疗科技有限公司于近日收到国家药品监督管理局颁发的2项《医疗器械注册证》，名称分别为：腺病毒抗原检测试剂盒、腺病毒抗原检测试剂盒。公司上述腺病毒抗原检测试剂注册证的获批，是对公司现有呼吸道病原体快检解决方案的有效补充，可满足不同应用场景和临床用途的需求，有助于提升公司在相关领域的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","688105","09996","BK0216","BK1100","09997","BK1574","159883","BK1583"],"gpt_icon":0},{"id":"2580429387","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580429387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580429387?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:33","pubTimestamp":1762162419,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，诺唯赞报收于23.41元，较前一交易日下跌0.43%，最新总市值为93.11亿元。近日，诺唯赞发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购期限为2025年6月19日至2026年6月18日，拟回购金额为500万元至1,000万元，用于员工持股计划或股权激励，回购价格不超过30元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300024295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2580403412","title":"每周股票复盘：诺唯赞（688105）Q3净利增74.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580403412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580403412?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:49","pubTimestamp":1762048149,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，诺唯赞报收于23.51元，较上周的22.46元上涨4.67%。本周，诺唯赞10月31日盘中最高价报23.67元。本周关注点来自业绩披露要点：诺唯赞2025年第三季度归母净利润同比增长74.55%。股本股东变化截至2025年9月30日，诺唯赞股东户数为9447户，较6月30日增加851户，增幅9.9%。业绩披露要点诺唯赞2025年前三季度实现营收9.52亿元，同比下降3.4%；归母净利润661.52万元，同比下降63.57%；扣非净利润-4334.77万元，同比下降45.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2579638907","title":"诺唯赞（688105）披露2025年第三季度报告，10月29日股价上涨0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579638907","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579638907?lang=zh_cn&edition=full","pubTime":"2025-10-29 22:23","pubTimestamp":1761747815,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，诺唯赞报收于23.33元，较前一交易日上涨0.95%，最新总市值为92.79亿元。该股当日开盘23.02元，最高23.51元，最低22.85元，成交额达4391.22万元，换手率为0.48%。近日，诺唯赞发布2025年第三季度报告。公告显示，公司年初至报告期末实现营业收入952,404,074.47元，较上年同期下降3.40%；归属于上市公司股东的净利润为6,615,186.89元，同比下降63.57%。截至2025年9月30日，公司总资产为5,006,396,044.02元，归属于上市公司股东的所有者权益为3,843,553,422.74元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900045219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2579490359","title":"图解诺唯赞三季报：第三季度单季净利润同比增长74.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579490359","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579490359?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:05","pubTimestamp":1761739545,"startTime":"0","endTime":"0","summary":"证券之星消息，诺唯赞2025年三季报显示，前三季度公司主营收入9.52亿元，同比下降3.4%；归母净利润661.52万元，同比下降63.57%；扣非净利润-4334.77万元，同比下降45.37%；其中2025年第三季度，公司单季度主营收入3.46亿元，同比上升2.84%；单季度归母净利润348.58万元，同比上升74.55%；单季度扣非净利润-1020.52万元，同比上升29.74%；负债率23.28%，投资收益347.17万元，财务费用332.41万元，毛利率69.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105"],"gpt_icon":0},{"id":"2576831736","title":"诺唯赞跌3.56% 2021年上市超募9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831736","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831736?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:49","pubTimestamp":1760950172,"startTime":"0","endTime":"0","summary":"中国经济网北京10月20日讯 诺唯赞 今日收报21.96元，跌幅3.56%。目前该股处于破发状态。 诺唯赞于2021年11月15日在上交所科创板上市，发行数量为4001.00万股，发行价格为55.00元/股，保荐机构为华泰联合证券有限责任公司，保荐代表人为王正睿、李皓。 诺唯赞首次公开发行股票的发行费用合计9137.98万元，华泰联合证券有限责任公司获得保荐及承销费用7263.92万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251020/31720765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688105","BK0216"],"gpt_icon":0},{"id":"2574450085","title":"每周股票复盘：诺唯赞（688105）已回购40,000股支付约97.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574450085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574450085?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:52","pubTimestamp":1760208733,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，诺唯赞报收于22.77元，较上周的23.21元下跌1.9%。本周，诺唯赞10月9日盘中最高价报23.42元。诺唯赞当前最新总市值90.56亿元，在生物制品板块市值排名32/50，在两市A股市值排名2052/5158。本周关注点公司公告汇总：诺唯赞已累计回购40,000股，支付资金总额973,813.67元。截至2025年9月30日，公司累计回购股份40,000股，占公司总股本397,734,544股的0.01%，实际回购价格区间为24.26元/股至24.36元/股，支付资金总额为973,813.67元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2574016189","title":"诺唯赞（688105）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574016189","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574016189?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:05","pubTimestamp":1760022321,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，诺唯赞报收于23.1元，较前一交易日下跌0.47%，最新总市值为91.88亿元。近日，诺唯赞发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，南京诺唯赞生物科技股份有限公司于2025年6月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购期限为2025年6月19日至2026年6月18日，拟回购金额为500万元至1,000万元，用于员工持股计划或股权激励，回购价格不超过30元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900035005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"gpt_icon":0},{"id":"2569977276","title":"诺唯赞(688105.SH)子公司产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2569977276","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569977276?lang=zh_cn&edition=full","pubTime":"2025-09-24 17:41","pubTimestamp":1758706913,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)发布公告，公司全资子公司南京诺唯赞医疗科技有限公司开发的多个神经系统系列诊断试剂产品，于近日取得我国多项《医疗器械注册证》。依托自有抗体技术平台，公司根据全球权威指南，持续丰富AD血检系列产品，同时围绕中枢神经系统重大疾病领域重点布局，创新开发帕金森病、脑损伤等精准检测、诊断类创新产品，致力于解决神经疾病领域未被满足的临床需求，不断提升公司化学发光平台的产品力和影响力，助力我国脑健康与认知障碍疾病诊疗服务水平提升，积极践行“健康中国战略”。本次产品注册证的取得仅代表公司相关产品获得国内市场准入资格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","688105","BK0216","BK1100","09996","09997","159883","BK1222"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766157294192,"stockEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":-0.151},{"period":"3month","weight":-0.0953},{"period":"6month","weight":-0.0614},{"period":"1year","weight":-0.1471},{"period":"ytd","weight":-0.091}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京诺唯赞生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"9447人(较上一季度增加9.90%)","perCapita":"42101股","listingDate":"2021-11-15","address":"江苏省南京市栖霞区经济技术开发区科创路红枫科技园C1-2栋东段1-6层","registeredCapital":"39773万元","survey":" 南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂、POCT诊断试剂和仪器。截至2025年6月30日，公司共获得121项发明专利授权，发明专利申请累计269项。","listedPrice":55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺唯赞,688105,诺唯赞股票,诺唯赞股票老虎,诺唯赞股票老虎国际,诺唯赞行情,诺唯赞股票行情,诺唯赞股价,诺唯赞股市,诺唯赞股票价格,诺唯赞股票交易,诺唯赞股票购买,诺唯赞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}